Ticker HubNYSE

JNJ

Johnson & Johnson

PHARMACEUTICAL PREPARATIONS

Latest price

$266.30+0.94%

As of Oct 26, 2026, 7:58 PM EDT · Market data by Massive

Market cap

$635.1B

Volume

5.9M

Previous close

$263.81

Day range

$264.97 – $272.36

Listed

Sep 25, 1944

Coverage

6 articles

Price performance

Recent trading

5 trading days · 15-minute intervals · ET
$271.73$267.52$263.32$259.12$254.92Tue, 10/20Wed, 10/21Thu, 10/22Fri, 10/23Mon, 10/26
Five-day open $255.50Latest interval $266.30

Newsroom

Latest JNJ coverage

a person holding a cell phone in front of a stock chart
Market MoversNewsOct 13, 2026

​Stock Market Today: Dow, S&P 500 and Nasdaq Slip as Bank Earnings and AI Selloff Rattle Wall Street

U.S. stocks were mixed on Tuesday as Wall Street weighed the first major bank earnings of the season against another wave of selling in semiconductor stocks.

FUNMUDRAMJNJ
Stock Market Today: Stocks Mixed Amid Tariff Concerns and Fed Leadership Drama cover
Market MoversNewsJul 16, 2025

Stock Market Today: Stocks Mixed Amid Tariff Concerns and Fed Leadership Drama

U.S. stocks were mixed on Wednesday, with the S&P 500 up slightly, while the Dow Jones Industrial Average and Nasdaq Composite wavered.

GSPCDJIIXICJNJ
Stock Market Today: Wall Street Rises as Investors Weigh Trump Tariff Shake-Up, Big Bank Earnings cover
Market MoversNewsApr 15, 2025

Stock Market Today: Wall Street Rises as Investors Weigh Trump Tariff Shake-Up, Big Bank Earnings

U.S. stocks ticked higher Tuesday as markets continued their chaotic ride through the Trump administration’s latest tariff whiplash.

HPEBABACJNJ
Inside the Acquisition Frenzy: The Top Reasons Why Giants like JNJ Can't Resist Shockwave Medical! cover
Market MoversNewsApr 3, 2024

Inside the Acquisition Frenzy: The Top Reasons Why Giants like JNJ Can't Resist Shockwave Medical!

In the wake of soaring speculation fueled by reports of potential acquisition talks with Johnson & Johnson, Shockwave Medical finds itself in the spotlight as investors weigh the prospects of a strategic deal

JNJSWAVBSXPEN
Decoded: Why Did Johnson & Johnson Spend $2 billion To Acquire Ambrx Biopharma? cover
Market MoversPharmaJan 20, 2024

Decoded: Why Did Johnson & Johnson Spend $2 billion To Acquire Ambrx Biopharma?

In a groundbreaking move, pharmaceutical giant Johnson & Johnson has set the stage for a significant leap forward in cancer treatment with its recent $2 billion acquisition of Ambrx Biopharma.

AMAMJNJ
Johnson & Johnson’s stock slammed after report it knew of asbestos in baby powder
NewsDec 14, 2018

Johnson & Johnson’s stock slammed after report it knew of asbestos in baby powder

[ad_1] Shares of Johnson & Johnson tumbled Friday, after a Reuters report that the drug and consumer-products firm knew for many years that its baby talcum powder was contaminated with asbestos, a identified carcinogen, that's alleged to have prompted most cancers in 1000's of its prospects. The stock 
 
 
 
 
 
 
 ...

JNJCFRADJIASPX
Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.